insights_auto
Why is ORX down 2,90%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,97 SEK
arrow_downward
-2,90%(-0,029) 1D
20 қар., 15:12:57 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
339,73 млн
Avg. vol.
785,30 м.
Volume
265,65 м.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
339,73 млн
Avg. vol.
785,30 м.
Volume
265,65 м.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
1 сағат бұрын
S&P 500 Premarket Movers Friday: Gainers and Losers
Coinpaper
·
9 минут бұрын
S&P 500 Price Prediction: S&P 500 Falls 2.3% Below 200-Day Average
Reuters
·
40 минут бұрын
SocGen sees S&P 500 ending 2027 at 8,500 on AI, earnings support
TradingView
·
3 минут бұрын
S&P 500 is on track for the worst week since the April 2025 'Liberation Day' sell-off
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com